Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Siemens Provides Breast Care Solutions

02.12.2008
Comprehensive solutions that follow the complete continuum of breast care Siemens Healthcare showcases the clinical workflow of breast cancer care at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago. From early detection and diagnosis through therapy and aftercare, Siemens demonstrates its comprehensive portfolio of innovations for women’s health.

Breast cancer is the most frequently diagnosed cancer in women. In 2007, 1.3 million cases were diagnosed and 465,000 women died worldwide1. The National Cancer Institute estimates that a woman has a 1 in 8 chance of developing breast cancer during her lifetime. But even with statistics as these, the good news is that advanced diagnostic and treatment technology developments have helped reduce death from breast cancer by approximately 24 percent since 1992.

“For clinicians, and certainly for patients, breast cancer care has now become a truly personalized clinical workflow,” said Thomas Miller, CEO, Workflow & Solutions, Siemens Healthcare. “The clinical focus is first on early detection, and then differential diagnosis, staging, and precise characterization of the nature of the disease so that an individualized and customized treatment plan can be selected. Siemens understands this, and we have unique technologies to deliver an integrated solution allowing our customers to deliver the best, as well as the most efficient standard of care.”

Through a unique combination of advanced imaging, laboratory diagnostics, and information technologies, Siemens’ innovations help physicians detect, diagnose and treat breast cancer in its earliest, most treatable stages, as well as providing them with comprehensive after-care solutions. This holistic approach enables shorter exams, streamlined workflow, and improved patient outcomes. With clinical guidelines suggesting different types of exams for breast care, imaging technologies are playing an increasing role in all stages of breast care. At RSNA, Siemens is showcasing its latest advancements in breast ultrasound and magnetic resonance imaging (MRI), as well as the next-generation of digital mammography systems.

Magnetom Espree – Pink

The American Cancer Society’s new screening guidelines recommend that high-risk women receive an annual MRI, which could impact up to 1.4 million women.1 Siemens’ latest innovation in MRI, the Magnetom Espree – Pink, is a dedicated MR breast scanner which combines the Open Bore design of the Magnetom Espree with the Sentinelle Vanguard for Siemens, a breast coil solution that offers exceptional breast imaging and biopsy access. Magnetom Espree – Pink offers unmatched patient comfort, unique applications, and an innovative workflow pushing MRI Breast Care to the next level.

The Magnetom Espree – Pink offers the same unprecedented level of patient comfort of the Magnetom Espree, the worlds first Open Bore MRI. Enabling feet-first and head-first positioning and excellent access to perform biopsies, the system has unparalleled openness with a 70 cm Open Bore and the shortest system on the market (125 cm) for increased comfort. This MR system provides a comprehensive portfolio of routine and advanced applications for breast care, including syngo VIEWS for routine imaging, syngo GRACE for spectroscopy, and syngo BLADE for motion-free imaging results. An integral part of Magnetom Espree – Pink is the design of the Sentinelle Vanguard coil for Siemens. This coil technology, combined with the system’s dedicated multi-modality workplace, creates a powerful solution that offers exceptional speed and versatility and enhanced workflow.

Acuson S2000 Automated Breast Volume Scanner (ABVS)

In a 1998 study published in the New England Journal of Medicine2, the detection rate for nonpalpable, invasive breast cancers increased by 42 percent in women with dense breasts when mammography was followed by an ultrasound exam. The Acuson S2000 ABVS3 system automatically and quickly acquires full-field sonographic volumes for comprehensive review and diagnosis of the breast streamlining workflow and reducing operator dependence and variability. The system also features the intuitive, anatomical coronal plane not available using conventional ultrasound. This view provides a more understandable representation of the global anatomy and architecture of the breast. Semi-automated reporting and comprehensive BI-RADS reporting capabilities further enhance the clinical workflow.

The Acuson S2000 ABVS system has an innovative, mobile in-suite design, combining the advanced Acuson S2000 ultrasound system with a transducer specifically designed for automated ultrasound breast volume imaging. To further optimize high-volume patient care, the system also supports innovative breast imaging applications, such as fatty tissue and eSie Touch elasticity imaging.

3D Tomosynthesis

The latest technology now under development in full-field mammography, breast tomosynthesis5 is a 3D imaging technology that acquires 2D projection images of a compressed breast at multiple angles during a sweep of the X-ray tube. Poised to enhance mammography, the new technology will take the two-dimensional images and reconstruct them to reveal depth – the third dimension of anatomy. Tomosynthesis slices have the potential to show tumors that are covered by overlaying tissue in 2D imaging.

Mammomat Inspiration

Siemens’ digital mammography platform Mammomat Inspiration is the first system in industry upgradeable on-site to tomosynthesis (WIP). Its basic system architecture including stand, generator, detector and software is already prepared for future 3D imaging with tomosynthesis. In addition the mammography platform is ideally suited for high-volume screening, diagnostics and stereotactic biopsy. At the moment,125 Mammomat Inspiration have already been installed worldwide, since its launch in December 2007. “Siemens’ unique strength is our ability to integrate in-vivo and in-vitro diagnostics with therapeutics and clinical workflow knowledge to support the worldwide battle against breast cancer,” said Miller. “Patient care and positive outcomes are at the core of our mission – and that is just how it should be.”

1Global Cancer Facts and Figures 2007.

2New England Journal of Medicine, Vol. 356, No. 5: 227-263.

3This product is pending 510(k) review and is not yet commercially available in the U.S.

4Caution: Investigational device. Limited by U.S. Federal Law to Investigational Use. This is a Works in Progress and not yet commercially available in U.S.

5Caution: Investigational device. Limited by U.S. Federal Law to Investigational Use. The information about Digital Breast Tomosynthesis is preliminary. This product is under development and not commercially available in the U.S., and its future availability cannot be ensured.

The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of €11.17 billion, orders of €11.78 billion, and group profit of €1.23 billion. (Preliminary figures)

Bianca Braun | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare

More articles from Health and Medicine:

nachricht Potential seen for tailoring treatment for acute myeloid leukemia
10.12.2018 | University of Washington Health Sciences/UW Medicine

nachricht UC San Diego researchers develop sensors to detect and measure cancer's ability to spread
06.12.2018 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

Im Focus: Substitute for rare earth metal oxides

New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals

Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.

Im Focus: A bit of a stretch... material that thickens as it's pulled

Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.

Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...

Im Focus: The force of the vacuum

Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.

The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

Expert Panel on the Future of HPC in Engineering

03.12.2018 | Event News

 
Latest News

Small but ver­sat­ile; key play­ers in the mar­ine ni­tro­gen cycle can util­ize cy­anate and urea

10.12.2018 | Life Sciences

New method gives microscope a boost in resolution

10.12.2018 | Physics and Astronomy

Carnegie Mellon researchers probe hydrogen bonds using new technique

10.12.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>